Search Results - "Hannan, Karen"

Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome by Harrington, Josephine, Jones, W. Schuyler, Udell, Jacob A., Hannan, Karen, Bhatt, Deepak L., Anker, Stefan D., Petrie, Mark C., Vedin, Ola, Butler, Javed, Hernandez, Adrian F.

“…Acute coronary syndrome (ACS) is frequently complicated by evidence of heart failure (HF). Those at highest risk for acute decompensated HF in the setting of…”
Get full text

Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease by Bethel, M Angelyn, Sourij, Harald, Stevens, Susanna R, Hannan, Karen, Lokhnygina, Yuliya, Adler, Amanda I, Peterson, Eric D, Holman, Rury R, Lopes, Renato D

“…Estimating cardiovascular (CV) event accrual is important for outcome trial planning. Limited data exist describing event accrual patterns in patients with…”
Get full text

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience by Mahaffey, Kenneth W, Hellkamp, Anne S, Patel, Manesh R, Hannan, Karen L, Schwabe, Kimberly, Nessel, Christopher C, Berkowitz, Scott D, Halperin, Jonathan L, Hankey, Graeme J, Becker, Richard C, Piccini, Jonathan P, Breithardt, Günter, Hacke, Werner, Singer, Daniel E, Califf, Robert M, Fox, Keith A A

“…To evaluate the previously reported excess of thromboembolic events during the 30 days after the end of study (EOS) visit when participants transitioned from…”
Get full text

Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials by Goyal, Akash, Schibler, Tony, Alhanti, Brooke, Hannan, Karen L, Granger, Christopher B, Blazing, Michael A, Lopes, Renato D, Alexander, John H, Peterson, Eric D, Rao, Sunil V, Green, Jennifer B, Roe, Matthew T, Rorick, Tyrus, Berdan, Lisa G, Reist, Craig, Mahaffey, Kenneth W, Harrington, Robert A, Califf, Robert M, Patel, Manesh R, Hernandez, Adrian F, Jones, W Schuyler

“…Randomized clinical trials (RCTs) are critical in advancing patient care, yet conducting such large-scale trials requires tremendous resources and…”
Get full text

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial by Giugliano, Robert P, Roe, Matthew T, Harrington, Robert A, Gibson, C Michael, Zeymer, Uwe, Van de Werf, Frans, Baran, Kenneth W, Hobbach, Hans Peter, Woodlief, Lynn H, Hannan, Karen L, Greenberg, Sally, Miller, Joanne, Kitt, Michael M, Strony, John, McCabe, Carolyn H, Braunwald, Eugene, Califf, Robert M

“…The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI)…”
Get full text

Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study) by Kandzari, David E, Chu, Alan, Brodie, Bruce R, Stuckey, Thomas A, Hermiller, James B, Vetrovec, George W, Hannan, Karen L, Krucoff, Mitchell W, Christenson, Robert H, Gibbons, Raymond J, Sigmon, Kristina N, Garg, Jyostna, Hasselblad, Victor, Collins, Kenneth, Harrington, Robert A, Berger, Peter B, Chronos, Nicholas A, Hochman, Judith S, Califf, Robert M

“…In a nonrandomized feasibility study of therapeutic hypothermia in acute myocardial infarction, 18 patients were treated with endovascular cooling (Alsius,…”
Get full text

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes by Holman, Rury R, Bethel, M. Angelyn, Mentz, Robert J, Thompson, Vivian P, Lokhnygina, Yuliya, Buse, John B, Chan, Juliana C, Choi, Jasmine, Gustavson, Stephanie M, Iqbal, Nayyar, Maggioni, Aldo P, Marso, Steven P, Öhman, Peter, Pagidipati, Neha J, Poulter, Neil, Ramachandran, Ambady, Zinman, Bernard, Hernandez, Adrian F

“…This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular…”
Get full text

Improved speed and stability of st-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute st-segment elevation myocardial infarction by Roe, Matthew T, Green, Cynthia L, Giugliano, Robert P, Gibson, C.Michael, Baran, Kenneth, Greenberg, Mark, Palmeri, Sebastian T, Crater, Suzanne, Trollinger, Kathleen, Hannan, Karen, Harrington, Robert A, Krucoff, Mitchell W

“…This sub-study of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) trial evaluated of the impact of combination reperfusion therapy…”
Get full text

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction by Giugliano, Robert P., Roe, Matthew T., Woodlief, Lynn H., Harrington, Robert A., Hannan, Karen L., Califf, Robert M., Gibson, C.Michael, Zeymer, Uwe, Van de Werf, Frans, Baran, Kenneth W., Hobbach, Hans-Peter, Greenberg, Sally, Miller, Joanne, Kitt, Michael M., Strony, John, McCabe, Carolyn H., Braunwald, Eugene

“…The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI)…”
Get full text

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic urial by Giugliano, Robert P

“…Objectives The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction…”
Get full text

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation Myocardial Infarction: Results of the integrilin and tenecteplase in acute myocardial Infarction (integriti) phase II angiographic trial. Commentary by GIUGLIANO, Robert P, ROE, Matthew T, GREENBERG, Sally, MILLER, Joanne, KITT, Michael M, STRONY, John, MCCABE, Carolyn H, BRAUNWALD, Eugene, CALIFF, Robert M, KLEIMAN, Neal S, HARRINGTON, Robert A, GIBSON, C. Michael, ZEYMER, Uwe, VAN DE WERF, Frans, BARAN, Kenneth W, HOBBACH, Hans-Peter, WOODLIEF, Lynn H, HANNAN, Karen L

Get full text

Feeding Habits and Marginal Organ Histochemistry of Aspidogaster conchicola (Trematoda: Aspidogastrea) by Huehner, Martin K., Hannan, Karen, Garvin, Mary

“…Feeding methods and the role of marginal organs of Aspidogaster conchicola were investigated by examining living worms, worms sectioned in situ, and by…”
Get full text

A63 Managing a blinded 9000-patient coumadin clinic using express mail and facsimile by Berdan, Lisa G., McDougal, Mark F., Moss, William E., Snapp, John W., Jett, Linda L., Hannan, Karen L., Friedman, Erika K., Berkowitz, Scott D., Lee, Robert, Grandy, Susan, Hainer, James W., Harrington, Robert A., for the CARS Investigators

Get full text